BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:mRNA-2808 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of mRNA-2808\, from ClinicalTrials.gov estim
 ates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07116616-3373@assetmemo.bio
DTSTAMP:20261121T005452Z
DTSTART;VALUE=DATE:20300617
DTEND;VALUE=DATE:20300618
SUMMARY:mRNA-2808: Phase 1/2 readout est. (NCT07116616)
DESCRIPTION:mRNA-2808\, phase 1/2\, Multiple Myeloma.\nStudy: A Study of mR
 NA-2808 in Participants With Relapsed or Refractory Multiple Myeloma\nEsti
 mated primary completion: 17 June 2030. This is a ClinicalTrials.gov estim
 ate\, not a confirmed readout date\, and it can move.\nDrug page: https://
 assetmemo.bio/drug/mrna-2808#upcoming-events\nRegistry record: https://cli
 nicaltrials.gov/study/NCT07116616
URL:https://assetmemo.bio/drug/mrna-2808#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
